Found 48 matching trials
Pevonedistat, Azacitidine (or Decitabine), and Venetoclax for the Treatment of Patients With Acute Myelogenous Leukemia PHASE1 This is a phase Ib study with a 3 + 3 dose escalation design followed by a ...
Show More Learn More & Join Trial
Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS) PHASE1 For the first 28 day cycle, all patients will be treated with single agent ...
Show More Location
Multiple Locations
Learn More & Join Trial
Decitabine and Venetoclax Treatment as Maintenance Therapy in Patients Post Allograft Stem Cell Transplant PHASE1 The goal of this interventional clinical trial is to determine if low doses...
Show More Location
Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center
Learn More & Join Trial
Study of 5-azacitidine in Combination With Vorinostat in Patients With Relapsed or Refractory Diffuse Large b Cell Lymphoma (DLBCL) PHASE1 This will be a phase I/II study of 5-azacitidine in combination with vorino...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
A Randomized Trial of Venetoclax-Based Induction Intensity in Newly Diagnosed Acute Myeloid Leukemia PHASE2 This randomized, open label, multi arm phase II trial will evaluate the eff...
Show More Location
Multiple Locations
Learn More & Join Trial
Gilteritinib Plus VA Followed By Consolidation Chemotherapy in Newly Diagnosed FLT3-ITD+ AML PHASE2 This clinical trial aims to evaluate whether molecular MRD-guided chemother...
Show More Location
The First Affiliated Hospital, Zhejiang University School of Medicine
Learn More & Join Trial
FLT3-ITD Targeted Therapy in Fit AML Patients PHASE2 This international, multicenter, randomized (1:1), open-label phase II/III ...
Show More Location
Multiple Locations
Learn More & Join Trial
Dose-Escalation Study of Oral Administration of LP-108 as Monotherapy and in Combination With Azacitidine in Patients With Relapsed or Refractory MDS, CMML, or AML PHASE1 A Phase 1, Multicenter, Open-label, Dose-escalation Study to Evaluate Safet...
Show More Location
University of Michigan
Learn More & Join Trial
Venetoclax Plus Hypomethylating Agents and Subcutaneous Cytarabine for CEBPA-Mutated AML PHASE1 The goal of this clinical trial is to learn if a treatment combination-vene...
Show More Location
The First Affiliated Hospital of Soochow University
Learn More & Join Trial
Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes PHASE2 This is a Phase II therapeutic trial combining Decitabine days 1-5 with ora...
Show More Location
Masonic Cancer Center, University of Minnesota
Learn More & Join Trial